Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  2016-06-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/INF.0000000000001263PMID 27276179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunology of the Fetus and Newborn

  2018cited by this paper
• Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children

  2015cited by this paper
• Colistin: How should It Be Dosed for the Critically Ill?

  2015cited by this paper
• Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.

  2015cited by this paper
• Avery's Neonatology: Pathophysiology and Management of the Newborn

  2015cited by this paper
• The Use of Colistin in Critically Ill Children in a Pediatric Intensive Care Unit

  2014cited by this paper
• Developmental pharmacokinetics in pediatric populations.

  2014cited by this paper
• Risk Factors and Outcomes of Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonatal Intensive Care Unit: A Case-case-control Study

  2013cited by this paper
• Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection

  2013cited by this paper
• Clinical features, risk factors, and outcome of carbapenem-resistant Acinetobacter baumannii bacteremia in a Thai neonatal intensive care unit

  2012cited by this paper
• Safety in treatment of ventilator‐associated pneumonia due to extensive drug‐resistant Acinetobacter Baumannii with aerosolized colistin in neonates: A preliminary report

  2011cited by this paper
• Intravenous Colistin Administration in Neonates

  2011cited by this paper
• fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

  2010cited by this paper
• Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration.

  2010cited by this paper
• Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

  2010cited by this paper
• Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models

  2009cited by this paper
• Intravenous Colistimethate (Colistin) Use in Critically Ill Children Without Cystic Fibrosis

  2009cited by this paper
• Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

  2009cited by this paper
• Use of colistin in children.

  2009cited by this paper
• Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.

  2007cited by this paper
• Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

  2006cited by this paper
• Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa

  2006cited by this paper
• Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis

  2005cited by this paper
• Developmental pharmacology--drug disposition, action, and therapy in infants and children.

  2003cited by this paper
• A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography.

  2001cited by this paper
• In Vitro Pharmacodynamic Properties of Colistin and Colistin Methanesulfonate against Pseudomonas aeruginosaIsolates from Patients with Cystic Fibrosis

  2001cited by this paper
• A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children.

  2000cited by this paper
• Sodium sulphomethyl derivatives of polymyxins.

  1967cited by this paper
• SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS.

  1964cited by this paper
• Total body water in children.

  1951cited by this paper

• Risk Factors and Outcomes of Extensively Drug-Resistant Gram-Negative Bacilli in Neonates with Late-Onset Sepsis.

  2026cites this paper
• Multimodal Implementations to Reduce Neonatal Ventilator-Associated Pneumonia and Colistin Use: An Interrupted Time Series

  2025cites this paper
• Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps

  2025cites this paper
• Paediatric colistin prescribing practices in South Africa: A clinician survey

  2025cites this paper
• Managing Drug-resistant Acinetobacter baumannii Infection in Premature Infants

  2025cites this paper
• Treatment Outcomes and Associated Factors of Intravenous Colistin for Nosocomial Infections in Pediatric Patients: A Retrospective Study in a University Hospital in Thailand

  2024influential citation
• Reintroduction of Legacy Antibiotics in Neonatal Sepsis: The Special Role of Fosfomycin and Colistin

  2024influential citation
• Appropriate use of colistin in neonates, infants and children: Interim guidance

  2023influential citation
• Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates

  2023cites this paper
• Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit

  2023cites this paper
• Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling

  2022cites this paper
• Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study.

  2021cites this paper
• No Increased Acute Kidney Injury Rate Through Giving an Intravenous Colistin Loading Dose in Pediatric Patients.

  2021cites this paper
• Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses

  2021cites this paper
• Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS)

  2021cites this paper
• Evidence of Dose Variability and Dosing Below the FDA and EMA Recommendations for Intravenous Colistin (Polymyxin E) Use in Children and Neonates.

  2020cites this paper
• Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam

  2020cites this paper
• Higher Optimization of Pharmacokinetic and Pharmacodynamic Parameters Through Loading Dose of Intravenous Colistin in Pediatric Patients.

  2020cites this paper
• Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.

  2019cites this paper
• Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.

  2019cites this paper
• The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants: A Review of the Literature.

  2019cites this paper
• Dose Suggestions for Intravenous Colistin in Pediatric Patients: Caution Required.

  2018influential citation
• The use of polymyxins to treat carbapenem resistant infections in neonates and children

  2018cites this paper
• Colistin Use in Neonates and Children With Infections Due to Carbapenem-resistant Bacteria

  2017cites this paper
• Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment

  2017cites this paper
• Usages de la colistine en médecine humaine et vétérinaire : exploration pharmacocinétique et problématique d'antibiorésistance

  2017cites this paper